Elpidera

Elpidera, the third venture company formed by Moderna, is focused exclusively on the advancement of messenger RNA (mRNA) Therapeutics for the treatment of rare diseases. Elpidera, which is derived from the Greek word elpida meaning "hope," is leveraging Moderna's mRNA platform, an entirely new in vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly.

Elpidera, the third venture company formed by Moderna, is focused exclusively on the advancement of messenger RNA (mRNA) Therapeutics for the treatment of rare diseases. Elpidera, which is derived from the Greek word elpida meaning "hope," is leverag...Show all